GLOBAL DIABETES DRUGS MARKET FORECAST 2019-2027
TREY
1
Insert or Drag & Drop your photo
GLOBAL DIABETES DRUGS MARKET FORECAST 20192027
MARKET OVERVIEW • The important driver for the growth in this market is the increase in the prevalence of diabetes which is because of the increasing obesity among people caused by unhealthy diets and sedentary lifestyles. •
The diabetes drugs market segments include diabetes type and product class.
• Diabetes drugs manufacturers offer products for use by both the types (type 1 and type 2) of diabetic patients. • Growing elderly population is also influencing the market growth in a big way as the life expectancy rate is rising and the birth rate is declining at the same time.
TREY
2
KEY FINDINGS
• The growth in the global diabetes drugs market is mainly driven by increased diabetic population and obesity rates in recent years. • The North American market holds the largest share of the global market. • The global diabetes drugs market is expected to grow at a CAGR of 6.50% during the forecast period of 2019-2027.
INTRODUCTION Global Diabetes Drugs market by Diabetes type, by Product class, by Non-Insulin & by geography.
TREY
3
TREY 4
Infographic
REQUEST FREE SAMPLE To know more about the latest trends and innovation in the “ Global Diabetes Drugs market”
Request free sample TREY
5
NORTH AMERICA DIABETES DRUGS MARKET • The expected CAGR of the North American diabetes drugs market over the forecast period of 2019-2027 is 4.98%. • The region has the world’s most established market for diabetes drugs and holds more than half of the total market share. • The US market holds the maximum share in the sale and distribution of diabetes drugs.
Request free sample TREY
6
EUROPE DIABETES DRUGS MARKET • The CAGR for the European market of diabetes drugs is expected to be 5.09% for the forecast period of 2019-2027. • The increase in life expectancy contributes to the increase in the number of diseases prevailing in the region, especially diabetes. Implications caused by diabetes such as CVDs, kidney failure, foot ulcers and damage to the eyes have made people in Europe more conscious about diabetes management.
Request free sample TREY
7
ASIA PACIFIC DIABETES DRUGS MARKET • The CAGR for the Asia Pacific diabetes drugs market is expected to be 10.82% for the forecast period of 2019-2027. • Economic development and rise in healthcare spending are expected to increase the demand for diabetes drugs further. • Despite a large number of people with diabetes in the region, awareness is still low, and therefore the situation needs to be addressed.
Request free sample TREY
8
COMPETITIVE INSIGHTS Leading brands in the global market of diabetes drugs are Eli Lilly And Company, AstraZeneca Plc., B.Braun Melsungen Ag, Novo Nordisk A/S, Sanofi, Diavacs Inc., Xoma Corp., Albireo Pharma Inc., Macrogenics Inc., Astellas Pharma, Glaxosmithkline, Merck, Pfizer and Xeris Pharmaceuticals.
TREY
9
ABOUT US Inkwood Research specializes in syndicated research reports, customized research reports and consulting services. We offer market intelligence studies across a range of industries including Technology, Chemicals, Materials, Healthcare and Energy. With 20 years of research experience, we ensure you efficient deliverables with global and country industry knowledge and research expertise. Our analysis covers North & South America, Europe, CEE, CIS, Middle East, Africa and Asia.
TREY
10
CONTACT US +1 857-302-4704 sales@inkwoodresearch.com https://www.inkwoodresearch.com/
TREY
11
THANK YOU Follow us on:
TREY
12 12